arrow
W

Wenhui Lou

the first affiliated hospital of zhengzhou university
H指数:24
被引数:2,253
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T4, N2 disease, positive resection margin, and receiving adjuvant chemotherapy

对于T4,N2疾病,切缘阳性并接受辅助化疗的胰腺癌患者,额外的辅助放疗可提高手术治疗后1年的生存率

2023-07-181
OAAI
Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies

通过循环无细胞DNA甲基化测序 (THUNDER) 进行非侵入性多癌检测: 开发和独立验证研究

2023-05-0138
OAAI
'Health-related quality of life in patients with advanced well-differentiated pancreatic and extra pancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double- blind, phase III trials (SANET-p and SANET-ep)' (vol 169, pg 1, 2022)
2023-01-010
PRE
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib

基线放射学特征可作为接受surufatinib治疗的胰腺神经内分泌肿瘤肝转移患者疗效的预测指标

2023-01-013
OA
Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)
2022-07-015
PRE
Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification
2022-02-0135
OAAI
Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study
2021-04-208
OA
Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning
2020-11-1813
OAAI